Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II Study

Clinical studies based on novel rationales and mechanisms of action of chemotherapy agents and cytokines can contribute to the development of new concepts and strategies of antitumor combination therapies. In previous studies, we investigated the paradoxical immunostimulating effects of some chemoth...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Oncol
Egile Nagusiak: Urbani, Francesca, Ferraresi, Virginia, Capone, Imerio, Macchia, Iole, Palermo, Belinda, Nuzzo, Carmen, Torsello, Angela, Pezzotti, Patrizio, Giannarelli, Diana, Pozzi, Anna Fausta, Santaquilani, Mariano, Roazzi, Paolo, Bastucci, Silvia, Catricalà, Caterina, La Malfa, Antonia, Vercillo, Giuseppe, Gualtieri, Novella, Buccione, Carla, Castiello, Luciano, Cognetti, Francesco, Nisticò, Paola, Belardelli, Filippo, Moschella, Federica, Proietti, Enrico
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2020
Gaiak:
Oncology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7069350/
https://ncbi.nlm.nih.gov/pubmed/32211314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00202
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak